Cited by 49Meta-analysis and systematic reviewsStatistical Methods in Clinical TrialsPain Mechanisms and Treatments

Adverse event reporting in randomised controlled trials of neuropathic pain: Considerations for future practice

Cornelius, Victoria R., Sauzet, Odile, Williams, John E., Ayis, Salma, Farquhar-Smith, Paul, Ross, Joy R., Branford, Ruth A., Peacock, Janet L.·2013·Pain

Abstract

High-quality information on the potential benefit and harm of a drug is required for patients and clinicians to make informed treatment decisions and to enable cost-effectiveness modeling to be undertaken. This systematic review describes the collection and reporting of adverse event data as presented in published clinical trials of neuropathic pain for the evaluation of antidepressant or antiepileptic drugs. A total of 74 studies in 16,323 patients published between 1965 and 2012 were identified, of which 43 were published from 2004 onwards. The review found that methods used to collect adverse event data, the frequency of collection, and the selection criteria used by authors for reporting adverse events vary substantially, and these events are often inadequately reported. Consequently, a potential synthesis of valuable harm information across trials is hampered. We make recommendations regarding the reporting of methods used to collect, assess, select, and present adverse event data in publications. Through the Core Outcome Measures in Effectiveness Trials (COMET) initiative, core outcome sets (which include effectiveness and harm) are developed by disease condition. To facilitate data synthesis for adverse events of drug therapies, we suggest that core outcome sets for harms could be developed by therapeutic class (ie, individualized for each class of drug). To improve comparability of information across trials collection methods need to be standardized for patient reports (spontaneous or prompted) and active surveillance (clinical examinations and laboratory tests). Uniform methods for presenting summary information regarding recurrent events, duration and timing of events requires further research.

Integrity signals

Registry

Crossref · 10.1016/j.pain.2012.08.012

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Missing or insufficient reporting of harm-related data is not specific to the probiotic field; similar issues have been reported regarding other interventions.

    “Missing or insufficient reporting of harm-related data is not specific to the probiotic field. Similar issues have been reported regarding other interventions.139–142”

    From Emerging issues in probiotic safety: 2023 perspectives (2023) · cites this paper as [141]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cornelius, V. R., Sauzet, O., Williams, J. E., Ayis, S., Farquhar-Smith, P., Ross, J. R., Branford, R. A., & Peacock, J. L.
Affiliations
  • Royal Marsden NHS Foundation Trust (GB)
  • Bielefeld University (DE)
  • King's College London (GB)
  • Imperial College London (GB)
Corresponding author
Cornelius, Victoria R.
Venue
Pain
Published
2013-02
Volume
154
Issue
2
Pages
213-220
ISSN
0304-3959 (ISSN-L)
OpenAlex
W1990065001
Cited by
49
References
20
Citations by year
2026: 1 · 2025: 3 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 13 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 2 · 2014: 4 · 2013: 2 · 2012: 1
FWCI
3.27
Type
journal article
Language
en
Open access
closed
Locations
  • Pain (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion)
  • Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
Funders
  • NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
  • National Institutes of Health
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
Keywords
adverse event reporting, neuropathic pain, antidepressants, antiepileptic drugs, core outcome set, COMET Initiative, adverse event monitoring, spontaneous reporting, active surveillance, trial reporting quality, drug safety
MeSH terms
Analgesics, Humans, Neuralgia, Randomized Controlled Trials as Topic, Adverse Drug Reaction Reporting Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review